We are live on ! Find out more
LMAT icon

LeMaitre Vascular

183 hedge funds and large institutions have $872M invested in LeMaitre Vascular in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 28

3% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 60

0.77% more ownership

Funds ownership: 84.85%85.62% (+0.77%)

0% more funds holding

Funds holding: 183183 (0)

6% less capital invested

Capital invested by funds: $928M → $872M (-$56.1M)

92% less call options, than puts

Call options by funds: $529K | Put options by funds: $6.89M

Holders
183
Holders Change
Holders Change %
0%
% of All Funds
2.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
62
Reduced
60
Closed
28
Calls
$529K
Puts
$6.89M
Net Calls
-$6.36M
Net Calls Change
+$3.36M
Name Holding Trade Value Shares
Change
Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$7.94M +$106K +2,362 +1%
Envestnet Asset Management
27
Envestnet Asset Management
Illinois
$7.75M +$273K +6,100 +4%
JP Morgan Chase
28
JP Morgan Chase
New York
$7.55M -$1.08M -24,097 -13%
Charles Schwab
29
Charles Schwab
California
$7.28M -$53.3K -1,190 -0.8%
Goldman Sachs
30
Goldman Sachs
New York
$7.1M +$102K +2,275 +2%
Principal Financial Group
31
Principal Financial Group
Iowa
$6.61M -$397K -8,873 -6%
Federated Hermes
32
Federated Hermes
Pennsylvania
$5.77M -$249K -5,568 -4%
PPA
33
Parametric Portfolio Associates
Washington
$5.42M +$144K +3,211 +3%
Morgan Stanley
34
Morgan Stanley
New York
$4.91M -$548K -12,242 -10%
N
35
Nuveen
North Carolina
$4.88M +$30.9K +691 +0.6%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$4.74M +$240K +5,362 +6%
Invesco
37
Invesco
Georgia
$4.63M -$152K -3,403 -3%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$4.45M +$325K +7,266 +8%
BCC
39
Bridge City Capital
Oregon
$3.32M -$16.2K -362 -0.5%
Wells Fargo
40
Wells Fargo
California
$3.13M +$449K +10,029 +18%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$2.91M -$877K -19,600 -24%
Renaissance Technologies
42
Renaissance Technologies
New York
$2.8M -$268K -6,000 -9%
Citadel Advisors
43
Citadel Advisors
Florida
$2.53M +$1.86M +41,649 +327%
Two Sigma Investments
44
Two Sigma Investments
New York
$2.3M -$1.23M -27,426 -36%
Swiss National Bank
45
Swiss National Bank
Switzerland
$2.16M +$161K +3,600 +8%
Legal & General Group
46
Legal & General Group
United Kingdom
$2.12M -$22.6K -506 -1%
Stifel Financial
47
Stifel Financial
Missouri
$2.03M +$158K +3,532 +9%
PCM
48
Perkins Capital Management
Minnesota
$1.95M
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$1.79M +$626 +14 +0%
CCG
50
Chatham Capital Group
Georgia
$1.79M +$25.3K +566 +1%

LMAT Hedge Fund Activity: Q1 2022 in Review

183 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2022, worth a combined $872M — down 6% from $928M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new LMAT positions and 28 closed out — a net gain of 3 holders — while 62 added to existing stakes and 60 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $14.7M. The largest seller was Amundi, cutting an estimated $3.63M.

  • 183 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $872M of LeMaitre Vascular stock for Q1 2022, down 6% quarter-over-quarter.
  • 31 funds opened new LeMaitre Vascular positions in Q1 2022 and 28 closed out, a net change of +3 holders.
  • The largest LeMaitre Vascular buyer in Q1 2022 was VOYA Investment Management, an estimated $14.7M added.
  • The largest LeMaitre Vascular seller in Q1 2022 was Amundi, an estimated $3.63M sold.

Based on aggregated 13F filings for Q1 2022.